We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Committee Details Methods Used to Inflate Off-Patent Drug Prices
Senate Committee Details Methods Used to Inflate Off-Patent Drug Prices
Four pharmaceutical companies that dramatically raised prices for decades-old, off-patent drugs all followed a series of steps designed to create and defend a monopoly on the product — allowing them to control the product’s prices with little, if any, market interference, according to a Senate committee investigation.